Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Clinical Pharmacokinetics
|
November 1, 1986
Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects
J J Savarese, P D Goldenheim, G B Thomas, et al.
Anesthesia and Analgesia
|
March 11, 1999
The nature of spontaneous recovery from mivacurium-induced neuromuscular block
C A Lien, M R Belmont, A Abalos, et al.
British Journal of Anaesthesia
|
January 1, 1983
Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium
H H Ali, J J Savarese, S J Basta, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
November 18, 2003
Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium
Takahiro Suzuki, Cynthia A Lien, Matthew R Belmont, et al.
Anesthesiology
|
March 18, 2010
Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: pharmacodynamics, acute cardiovascular effects, and preliminary toxicology
Hiroshi Sunaga, Jaideep K Malhotra, Edward Yoon, et al.
Anesthesiology
|
July 1, 1981
Role of histamine in the hypotensive action of d-tubocurarine in humans
J Moss, C E Rosow, J J Savarese, et al.
Anesthesiology
|
March 18, 2010
Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs
Paul M Heerdt, Jaideep K Malhotra, Brian Y Pan, et al.
Anesthesiology
|
July 1, 1996
Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats
W B Wastila, R B Maehr, G L Turner, et al.
Cancer
|
June 1, 1989
Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design
D Cundiff, K McCarthy, J J Savarese, et al.
Anesthesiology
|
April 17, 2004
Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs
Paul M Heerdt, Richard Kang, Andrew The', et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Clinical Pharmacokinetics
|
November 1, 1986
Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects
J J Savarese, P D Goldenheim, G B Thomas, et al.
Anesthesia and Analgesia
|
March 11, 1999
The nature of spontaneous recovery from mivacurium-induced neuromuscular block
C A Lien, M R Belmont, A Abalos, et al.
British Journal of Anaesthesia
|
January 1, 1983
Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium
H H Ali, J J Savarese, S J Basta, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
November 18, 2003
Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium
Takahiro Suzuki, Cynthia A Lien, Matthew R Belmont, et al.
Anesthesiology
|
March 18, 2010
Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: pharmacodynamics, acute cardiovascular effects, and preliminary toxicology
Hiroshi Sunaga, Jaideep K Malhotra, Edward Yoon, et al.
Anesthesiology
|
July 1, 1981
Role of histamine in the hypotensive action of d-tubocurarine in humans
J Moss, C E Rosow, J J Savarese, et al.
Anesthesiology
|
March 18, 2010
Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs
Paul M Heerdt, Jaideep K Malhotra, Brian Y Pan, et al.
Anesthesiology
|
July 1, 1996
Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats
W B Wastila, R B Maehr, G L Turner, et al.
Cancer
|
June 1, 1989
Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design
D Cundiff, K McCarthy, J J Savarese, et al.
Anesthesiology
|
April 17, 2004
Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs
Paul M Heerdt, Richard Kang, Andrew The', et al.
Page
of 8